Abstract
to analyze the sociodemographic and clinical profile of women with gynecological cancer in brachytherapy. a cross-sectional study including records of 1,930 visits of women in brachytherapy assisted between 2006-2016 in Santa Catarina (Brazil). Collection was performed in 2019, in an institutional bank, submitted to frequency measurements, chi-square test, 95% confidence intervals, significance level of 0.05. women aged 40-59 years (47.2%), white (93.3%); with elementary school (65%); cervical cancer (78.5%); stages II-III (73.3%) figured prominently. In the comparison of staging proportions in the topography variable, a higher proportion of malignant neoplasm of cervix uteri unspecified in the grouped III-IV staging (84.6%). the profile analysis shows the need for screening and health education for prevention and/or early detection of gynecological cancers and training of nurses specialized in radiotherapy to care for women's health.
Highlights
Gynecological cancers cover the cervix uteri, corpus uteri, ovary, vulva, vagina, and uterine tubes
In Brazil, in 2018, its incidence was approximately 16,298 and mortality affected 8,079 women. This epidemiology tends to decrease with the implementation of preventive measures and early detection of non-malignant neoplastic lesions, considering that the disease is linked to repeated infection by the Human Papilloma Virus (HPV), which can be prevented by screening and vaccination programs[1,2,3,4]
There was a difference in the staging proportions; a higher proportion of malignant neoplasm of the cervix uteri was unspecified in the grouped staging III and IV (84.6%) and a higher proportion of malignancy of the endometrium with grade I and II grouped (24.2%) when compared to the proportion of the other categories of staging
Summary
Gynecological cancers cover the cervix uteri, corpus uteri, ovary, vulva, vagina, and uterine tubes. The number of cases of cervical cancer has a significant reduction, as in the United States, which has an incidence of 14,065 and a mortality rate of 5,266. This reduction had a direct influence on the immunization of boys and girls before starting their sex life, because 75% of people who have an active sex life will be infected with this virus at some point. The vaccine prevents HPV infection 6 and 11 (related to anogenital warts) and 16 and 18 (related to cervical cancer)(1,4)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
